Catalyst Wire Dossier Catalyst Wire Dossier

ELAPR (Formulation B)

· Elastagen Pty Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ELAPR (Formulation B), covering 2012-10-15 to 2012-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Two Formulations of ELAPR Compared to Restylane® Vital Light Following Repeat Implants in the Upper Arm Dermis [Phase 1]

See pricing